Influence of Three Probiotics Strains, <i>Lactobacillus rhamnosus</i> GG, <i>Bifidobacterium animalis</i> subsp. <i>Lactis</i> BB-12 and <i>Saccharomyces boulardii</i> CNCM I-745 on the Biochemical and Haematological Profiles and Body Weight of Healthy Rabbits

Influence of Three Probiotics Strains, <i>Lactobacillus rhamnosus</i> GG, <i>Bifidobacterium animalis</i> subsp. <i>Lactis</i> BB-12 and <i>Saccharomyces boulardii</i> CNCM I-745 on the Biochemical and Haematological Profiles and Body Weight of Healthy Rabbits

This study aimed to investigate the effects of three strains of probiotics, these being <i>Lactobacillus rhamnosus</i> GG, <i>Bifidobacterium animalis</i> subsp. <i>Lactis</i> BB-12 and <i>Saccharomyces boulardii</i> CNCM I-745, on the body weight, ani...

Full description

Bibliographic Details
Main Authors:	Louiza Kadja, Amira Leila Dib, Nedjoua Lakhdara, Assia Bouaziz, Elena Espigares, Mohammed Gagaoua
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Biology
Subjects:	rabbits diet probiotics immunity health microbiota
Online Access:	https://www.mdpi.com/2079-7737/10/11/1194

Similar Items

Study of Probiotic Effects of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB-12 and <i>Lactobacillus plantarum</i> 299v Strains on Biochemical and Morphometric Parameters of Rabbits after Obesity Induction
by: Assia Bouaziz, et al.
Published: (2021-02-01)

Influence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune system
by: Stier H, et al.
Published: (2016-09-01)

Inhibition of In Vitro <i>Clostridioides difficile</i> Biofilm Formation by the Probiotic Yeast <i>Saccharomyces boulardii</i> CNCM I-745 through Modification of the Extracellular Matrix Composition
by: Pierre-Alexandre Lacotte, et al.
Published: (2022-05-01)

Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
by: Paola Brun, et al.
Published: (2017-01-01)

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption
by: Terciolo C, et al.
Published: (2019-02-01)

Protective effect of Saccharomyces boulardii CNCM I-745 on the development of inflammatory osteoclasts and inflammatory bone destruction
by: Maria-Bernadette Madel, et al.
Published: (2020-10-01)

Effect of Co-Fermentation of <i>Saccharomyces boulardii</i> CNCM-I745 with Four Different Probiotic Lactobacilli in Coffee Brews on Cell Viabilities and Metabolic Activities
by: Mei Zhi Alcine Chan, et al.
Published: (2023-02-01)

Efficacy of <i>Saccharomyces boulardii</i> CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19
by: Igor V. Maev, et al.
Published: (2022-11-01)

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis
by: Maria-Bernadette Madel, et al.
Published: (2023-02-01)

The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin
by: Rodolphe Pontier-Bres, et al.
Published: (2015-10-01)

Effect of Chilled Storage on Antioxidant Capacities and Volatile Flavors of Synbiotic Yogurt Made with Probiotic Yeast <i>Saccharomyces boulardii</i> CNCM I-745 in Combination with Inulin
by: Abid Sarwar, et al.
Published: (2022-07-01)

Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota
by: Madeleine Spatz, et al.
Published: (2023-08-01)

Saccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers
by: Ciaran Patrick Kelly, et al.
Published: (2019-03-01)

Effectiveness of Saccharomyces boulardii CNCM I-745 in Adult Indian Patients with Diarrhoea: A Real-world, Multicentre, Retrospective, Comparative Study
by: Bhaskar Bikash Pal, et al.
Published: (2024-04-01)

A double‐blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I‐745 in formula‐fed preterm infants
by: Lingfen Xu, et al.
Published: (2016-05-01)

A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants
by: Lingfen Xu, et al.
Published: (2016-05-01)

Saccharomyces boulardii Strain CNCM I-745 Modifies the Mononuclear Phagocytes Response in the Small Intestine of Mice Following Salmonella Typhimurium Infection
by: Lidia Ibáñez, et al.
Published: (2019-04-01)

CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review
by: Margret I Moré, et al.
Published: (2018-02-01)

Anti-Biofilm Properties of <i>Saccharomyces cerevisiae</i> CNCM I-3856 and <i>Lacticaseibacillus rhamnosus</i> ATCC 53103 Probiotics against <i>G. vaginalis</i>
by: Samuele Sabbatini, et al.
Published: (2020-08-01)

Impact of <i>Lacticaseibacillus rhamnosus</i> GG on the Emulsion Stability of Raw Milk
by: Raphael Dos Santos Morais, et al.
Published: (2021-05-01)

Effectiveness of Saccharomyces Boulardii CNCM I-745 probiotic in acute inflammatory viral diarrhoea in adults: results from a single-centre randomized trial
by: Marcela AG Salazar-Parra, et al.
Published: (2023-07-01)

Effect of Feeding <i>Saccharomyces cerevisiae boulardii</i> CNCM I-1079 to Sows and Piglets on Piglets’ Immune Response after Vaccination against <i>Actinobacillus pleuropneumoniae</i>
by: Fernando Bravo de Laguna, et al.
Published: (2022-09-01)

Dietary <i>Saccharomyces cerevisiae boulardii </i>CNCM I-1079 Positively Affects Performance and Intestinal Ecosystem in Broilers during a <i>Campylobacter jejuni</i> Infection
by: Francesca Romana Massacci, et al.
Published: (2019-11-01)

Risk factors related to bacterial contamination by <i>Enterobacteriaceae</i> and fecal coliforms and the prevalence of <i>Salmonella spp.</i> in Algerian farms, slaughterhouses and butcheries: a two-year follow-up study
by: Khireddine Ghougal, et al.
Published: (2021-07-01)

Safety and efficacy of Lactobacillus rhamnosus CNCM I‐3698 and Lactobacillus farciminis CNCM I‐3699 as a feed additive for all animal species
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2020-04-01)

Respiratory Delivery of <i>Lacticaseibacillus rhamnosus</i> GG by Vibrating-Mesh and Jet Nebulisation
by: Alex Seungyeon Byun, et al.
Published: (2024-10-01)

UPLC-Q-TOF-MS based metabolomics and chemometric analyses for green tea fermented with Saccharomyces boulardii CNCM I-745 and Lactiplantibacillus plantarum 299V
by: Rui Wang, et al.
Published: (2022-01-01)

Safety and efficacy of Sorbiflore® ADVANCE (Lactobacillus rhamnosus CNCM I‐3698 and Lactobacillus farciminis CNCM I‐3699) as a feed additive for chickens for fattening
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2020-05-01)

Preliminary Evaluation of the Safety and Probiotic Potential of <i>Akkermansia muciniphila</i> DSM 22959 in Comparison with <i>Lactobacillus rhamnosus</i> GG
by: Autilia Cozzolino, et al.
Published: (2020-01-01)

Monoassociation of Preterm Germ-Free Piglets with <i>Bifidobacterium animalis</i> Subsp. <i>lactis</i> BB-12 and Its Impact on Infection with <i>Salmonella</i> Typhimurium
by: Alla Splichalova, et al.
Published: (2021-02-01)

Safety and efficacy of a feed additive consisting of Lacticaseibacillus rhamnosus CNCM I‐3698 and Companilactobacillus sp. CNCM I‐3699 for weaned piglets (STI Biotechnologie)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2023-04-01)

Safety and efficacy of a feed additive consisting of Lacticaseibacillus rhamnosus CNCM I‐3698 and Companilactobacillus sp. CNCM I‐3699 for chickens for fattening (STI Biotechnologie)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2023-03-01)

Dry Powder Inhaler Formulation of <i>Lactobacillus rhamnosus GG</i> Targeting <i>Pseudomonas aeruginosa</i> Infection in Bronchiectasis Maintenance Therapy
by: The-Thien Tran, et al.
Published: (2024-07-01)

Milk Fermentation by <i>Lacticaseibacillus rhamnosus</i> GG and <i>Streptococcus thermophilus</i> SY-102: Proteolytic Profile and ACE-Inhibitory Activity
by: Jessica Lizbeth Sebastián-Nicolas, et al.
Published: (2021-10-01)

Postbiotic Fractions of Probiotics <i>Lactobacillus plantarum</i> 299v and <i>Lactobacillus rhamnosus</i> GG Show Immune-Modulating Effects
by: Agnieszka Magryś, et al.
Published: (2023-10-01)

Effect of Yogurt Ice Cream on the Viability and Antidiabetic Potential of the Probiotics <i>Lactobacillus acidophilus</i>, <i>Lacticaseibacillus rhamnosus</i>, and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> after In Vitro Digestion
by: Rinrada Talearngkul, et al.
Published: (2023-12-01)

Efficacy of a feed additive consisting of Bacillus subtilis strains CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 for all animal species (MiXscience)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2023-03-01)

Safety and efficacy of a feed additive consisting of Bacillus subtilis strains CNCM I‐4606, CNCM I‐5043 and CNCM I‐4607 and Lactococcus lactis CNCM I‐4609 for all animal species (Nolivade)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2021-11-01)

Effect of the <i>Bifidobacterium animalis</i> Subsp. <i>Lactis</i>, BB-12<sup>®</sup> on <i>Cronobacter sakazakii</i> Growth in Infant Formulas with Different Acid-Buffering Capacities
by: Anthimia Batrinou, et al.
Published: (2024-12-01)

Safety and efficacy of a feed additive consisting of Lacticaseibacillus rhamnosus CNCM I‐3698 and Companilactobacillus sp. CNCM I‐3699 for all animal species (STI Biotechnologie)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2023-03-01)